1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 28
2.4 Emerging Opportunities and Market Trends 31
2.5 Porter's Fiver Forces Analysis 35
3 Segmentation of Europe Market by Source 39
3.1 Market Overview by Source 39
3.2 Synthetic API 41
3.2.1 Branded Synthetic API 42
3.2.2 Generic Synthetic API 43
3.3 Semi-synthetic API 44
3.4 Natural Origin 45
4 Segmentation of Europe Market by Type 46
4.1 Market Overview by Type 46
4.2 Standard API 48
4.3 High Potency API (HPAPI) 49
4.3.1 Branded HPAPI 50
4.3.2 Generic HPAPI 51
5 Segmentation of Europe Market by Therapeutic Area 52
5.1 Market Overview by Therapeutic Area 52
5.2 Infectious Diseases 54
5.3 Oncology 55
5.4 Ophthalmology 56
5.5 Cardiovascular Disorders 57
5.6 Central Nervous System 58
5.7 Respiratory Disorders 59
5.8 Metabolic Diseases 60
5.9 Other Applications 61
6 Segmentation of Europe Market by Application 62
6.1 Market Overview by Application 62
6.2 Clinical Use 64
6.3 Commercial Use 65
7 Segmentation of Europe Market by Manufacturer Type 66
7.1 Market Overview by Manufacturer Type 66
7.2 Pharmaceutical Companies 68
7.3 CMOs 70
8 European Market 2020-2027 by Country 72
8.1 Overview of European Market 72
8.2 UK 75
8.3 France 77
8.4 Germany 79
8.5 Spain 81
8.6 Italy 83
8.7 Russia 85
8.8 Rest of European Market 87
9 Competitive Landscape 89
9.1 Overview of Key Vendors 89
9.2 New Product Launch, Partnership, Investment, and M&A 92
9.3 Company Profiles 93
Aurobindo Pharma Ltd. 93
Cambrex Corporation 95
Catalent, Inc. 96
Dr. Reddy's Laboratories Ltd. 97
GlaxoSmithKline plc 98
Lonza Group 99
Merck & Co., Inc. 100
Mylan N.V. 101
Novartis AG 102
Pfizer Inc. 103
Sun Pharmaceutical Industries Ltd. 104
Teva Pharmaceutical Industries Ltd. 105
Wuxi AppTec Co., Ltd. 106
10 Investing in Europe Market: Risk Assessment and Management 107
10.1 Risk Evaluation of Europe Market 107
10.2 Critical Success Factors (CSFs) 110
Related Reports and Products 113